2025-08-03 - Analysis Report
Okay, here's an analysis of Sempra (SRE) based on the provided data, formatted for a concise English report:

## Sempra (SRE) Stock Analysis

**Company Overview:** Sempra is an energy infrastructure company focused on delivering electricity and natural gas.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (SRE):** 15.65%
*   **Cumulative Return (VOO):** 94.15%
*   **Absolute Deviation (Current):** -66.4%
*   **Relative Deviation (Current):** 9.4% (Indicates SRE is near the low end of its historical performance range relative to VOO)

| Year       | CAGR   | MDD   | Alpha   | Beta  | Cap (B) |
| :----------- | :----- | :----- | :------ | :---- | :------ |
| 2015-2017  | -11.0% | 11.6%  | -40.0% | -5.0 | 34.9    |
| 2016-2018  | -8.0%  | 71.1%  | -26.0% | -0.4  | 35.3    |
| 2017-2019  | 25.0%  | 71.1%  | -4.0%  | -0.2  | 49.4    |
| 2018-2020  | 13.0%  | 71.1%  | -7.0%  | -0.1  | 41.5    |
| 2019-2021  | 12.0%  | 56.9%  | -36.0% | -0.0  | 43.1    |
| 2020-2022  | 1.0%   | 68.0%  | -1.0%  | -0.0  | 50.4    |
| 2021-2023  | 25.0%  | 69.8%  | 7.0%   | 0.4   | 48.7    |
| 2022-2024  | 14.0%  | 69.8%  | -11.0% | 0.6   | 57.2    |
| 2023-2025  | -18.0% | 70.8%  | -64.0% | 1.1   | 52.8    |

**Analysis:** Sempra has significantly underperformed the S&P 500 over the period examined. The negative alpha values in most periods suggest underperformance relative to the market. The beta values are low, indicating lower volatility than the market, with a trend of gradually rising beta. The recent year shows a significant drop in CAGR and a large negative alpha.

**2. Recent Price Action**

*   **Current Price:** \$80.97
*   **Previous Close:** \$81.68
*   **Change:** -\$0.87
*   **5-day Moving Average:** \$81.06
*   **20-day Moving Average:** \$77.78
*   **60-day Moving Average:** \$76.68

**Analysis:** The price is slightly below the 5-day moving average, but above both the 20-day and 60-day averages, indicating a short-term pullback but a potential continuing uptrend in the medium term. The negative change from the previous close may be a sign of recent negative pressures.

**3. Indicators & Signals**

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 80.51 (Overbought)
*   **PPO:** 0.48
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (9 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment (\$1,000.00) (Cash Ratio: 0% on 2025-08-01)
*   **Recent (20-day) Relative Deviation Change:** 2.8 (+): Short-term increase
*   **Expected Return (%):** -214.8 (Significant underperformance vs. S&P 500 expected over a 2+ year investment horizon).
*   **Price volatility:** {'price': 80.97, 'previousClose': 81.68, 'change': -0.87} indicates a small decrease but should be considered when viewed with other indicators.

**Analysis:** The RSI indicates the stock is overbought, suggesting a potential pullback. The PPO is positive, indicating a potential uptrend. Despite the low MRI, the Hybrid Signal suggests caution, recommending buying 80% with a relatively small monthly investment. The *very* negative expected return is a major red flag, indicating significant projected underperformance compared to the S&P 500.

**4. Recent News & Events**

*   **2025-08-01:** Sempra in the news due to business developments, regulatory changes, or market events.
*   **2025-08-03:** Analysts discussing Sempra's performance and outlook.
*   **2025-07-31:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-30:** Market experts highlight both risks and opportunities; advise monitoring news.

**Analysis:** Recent news and events suggest significant activity surrounding Sempra, including volatility and analyst discussions. Investors should monitor news and company announcements for more details.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
| :--------- | :--- | :-------- |
| 2025-05-08 | 1.39 | 3.68 B$ |
| 2024-11-06 | 1.01 | 2.57 B$ |
| 2024-08-06 | 1.13 | 2.48 B$ |
| 2024-05-07 | 1.27 | 3.70 B$ |
| 2025-05-08 | 1.27 | 3.70 B$ |

**Analysis:** The EPS and revenue figures show some fluctuation. Reviewing the data, the last row shows duplicated figures, potentially an error in the data. The trend is generally positive, with revenue in the \$2.48B - \$3.70B range.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :-------------- |
| 2025-03-31 | \$3.80B   | 47.21%         |
| 2024-12-31 | \$3.76B   | 49.23%         |
| 2024-09-30 | \$2.78B   | 44.49%         |
| 2024-06-30 | \$3.01B   | 44.20%         |
| 2024-03-31 | \$3.64B   | 46.04%         |

**Capital and Profitability:**

| Quarter    | Equity     | ROE   |
| :--------- | :--------- | :---- |
| 2025-03-31 | \$31.66B   | 2.90% |
| 2024-12-31 | \$31.24B   | 2.16% |
| 2024-09-30 | \$29.72B   | 2.18% |
| 2024-06-30 | \$29.50B   | 2.46% |
| 2024-03-31 | \$29.16B   | 2.79% |

**Analysis:** The revenue and profit margin show fluctuations, but overall, the company seems profitable. Equity and ROE also show some variance, with equity steadily increasing and ROE varying within a small range.

**7. Overall Assessment**

Sempra (SRE) presents a mixed picture. While the MRI suggests low market risk, the significant underperformance compared to the S&P 500 and the negative expected return are concerning. The RSI indicates that the stock might be overbought in the short term. Recent news and events suggest potential catalysts, but it's crucial to investigate these further. Although the company is profitable, its negative Alpha raises concerns about its long-term investment potential.
